20170207-大华继显-Regional_Morning_Notes_24页_1mb
报告摘要
Regional Morning Notes Summary
Core Content
This document is a Regional Morning Notes report dated Tuesday, 07 February 2017, focusing on China, Indonesia, Malaysia, and Singapore markets. It provides investment recommendations, company updates, key indices, and valuation insights for various stocks and sectors.
Main Points
China Strategy: February Conviction Calls
- Alpha Picks: Alibaba Group, BEWG, CITICS, CRCC, CSPC, CSA, Lee & Man Paper, MGM China, UMF, and Sunac China.
- Key Catalysts: Full-year results announcements in Feb-Mar 17, potential infrastructure investment policies, and strong performance in online marketing and cloud business.
- Action Taken:
- Take profit on Sunny Optical.
- Add Alibaba Group, China Southern Airlines, and CRL to the BUY list.
- Add MGM China to the SELL list.
Indonesia Strategy
- Alpha Picks: MAPI, AISA, MPPA, BBNI, PTPP, and AALI.
- Sector Adjustment: Increased exposure in the consumer sector.
Malaysia Sector: Technology
- OSAT (Original Equipment Manufacturer and Semiconductor Technology): The launch of new-generation smartphones in Sep 17 is expected to drive a strong replacement cycle.
- Key Beneficiaries: Globetronics and Inari.
Malaysia Small/Mid Cap Highlights
- Ann Joo Resources (AJR MK):
- Expected to deliver strong earnings in 2017 with high ASP and lower coal prices.
- Benefits from China's industry consolidation.
Singapore Results
- Frasers Logistics & Industrial Trust (FLT SP):
- Strong performance in 1QFY17.
- Trading at S$0.96, with a target of S$1.11.
Thailand Update
- Diamond Building Products (DRT TB):
- Share price has not yet factored in new ready-made housing business.
- Maintain BUY.
Key Indices
| Index | Previous Close | 1D % | 1W % | 1M % | YTD % |
|---|---|---|---|---|---|
| DJIA | 20052.4 | -0.1 | 0.4 | 0.4 | 1.5 |
| S&P 500 | 2292.6 | -0.2 | 0.5 | 0.7 | 2.4 |
| FTSE 100 | 7172.2 | -0.2 | 0.8 | -0.5 | 0.4 |
| AS30 | 5665.4 | -0.1 | -0.9 | -2.5 | -0.9 |
| CSI 300 | 3373.2 | +0.3 | +0.3 | +0.8 | +1.9 |
| FSSTI | 3056.9 | +0.5 | -0.3 | +3.2 | +6.1 |
| HSCEI | 9840.3 | +1.6 | -0.1 | +2.4 | +4.7 |
| HSI | 23348.2 | +0.9 | -0.1 | +3.8 | +6.1 |
| JCI | 5396.0 | +0.7 | +1.8 | +0.9 | +1.9 |
| KLCI | 1691.2 | +0.4 | -0.1 | +0.9 | +3.0 |
| KOSPI | 2077.7 | +0.2 | -0.3 | +1.4 | +2.5 |
| Nikkei 225 | 18976.7 | +0.3 | -2.0 | -2.5 | -0.7 |
| SET | 1589.1 | +0.4 | -0.1 | +1.1 | +3.0 |
| TWSE | 9538.0 | +0.9 | +2.2 | +1.8 | +3.1 |
| BDI | 752 | -2.3 | -7.8 | -21.9 | -21.7 |
| CPO (RM/mt) | 3297 | -0.0 | -0.1 | +1.1 | +3.1 |
| Brent Crude (US$/bbl) | 56 | -1.6 | +1.2 | -2.1 | -1.6 |
Top Picks
BUY
- Alibaba Group (BABA US): Target price US$130, upside 29%. Strong online marketing and cloud growth, global expansion.
- BEWG (371 HK): Target price HK$7.60, upside 40.5%. Benefiting from PPP initiatives and government relationships.
- CITICS (6030 HK): Target price HK$19.90, upside 25.16%. Expected to benefit from A-share IPO approvals.
- CRCC (1186 HK): Target price HK$12.80, upside 18.3%. Expected to benefit from new PPP policies.
- CSPC (1093 HK): Target price HK$10.00, upside 14.2%. NBP injection and oncology products expected to drive growth.
- Lee & Man Paper (2314 HK): Target price HK$8.00, upside 14.1%. Benefiting from containerboard price increases.
- UMF (2666 HK): Target price HK$10.26, upside 57.8%. Revenue contribution from Xi'an project.
SELL
- MGM China (2282 HK): Target price HK$12.50, downside 15.5%. Missed expectations due to market share loss and delayed project openings.
- Sunac China (1918 HK): Target price HK$4.34, downside 37.3%. Aggressive landbanking and potential price cuts hurt margins.
Key Assumptions
-
GDP (yoy):
- US: 2.7
- Euro Zone: 1.1
- Japan: 0.9
- Singapore: 1.8
- Malaysia: 4.5
- Thailand: 3.3
- Indonesia: 5.2
- Hong Kong: 1.8
- China: 6.2
-
Brent Crude (US$/bbl):
- 2016: 45
- 2017F: 56
- 2018F: 61
-
CPO (RM/mt):
- 2016: 2,653
- 2017F: 2,600
- 2018F: 2,500
Corporate Events
| Event | Venue | Begin | Close |
|---|---|---|---|
| PTT Exploration and Production Roadshow | Singapore | 6 Feb | 7 Feb |
| Luncheon with Keppel T&T | Singapore | 10 Feb | 10 Feb |
| Luncheon with Kim Loong Resources | Malaysia | 13 Feb | 13 Feb |
| Tea Session with Valuetronics | Singapore | 13 Feb | 13 Feb |
| Tea Session with Duty Free International | Singapore | 17 Feb | 17 Feb |
| SGX-UOB Kay Hian Corporate Day | Taipei | 21 Feb | 21 Feb |
| UOB Kay Hian ASEAN Conference | Taipei | 22 Feb | 22 Feb |
| Group Meeting with Bumilama Agri | Singapore | 27 Feb | 27 Feb |
| Annual Plantation Outlook Seminar | Malaysia | 6 Mar | 6 Mar |
| Roadshow with Guotai Junan | Hong Kong | 7 Mar | 8 Mar |
Company Updates
Microport (853 HK)
- Positive Profit Alert: Net profit of at least US$10m in 2016 (vs. US$11.4m loss in 2015).
- Growth Drivers:
- Sales ramp-up of Firehawk in domestic and EU markets.
- Continued reduction of net loss in orthopaedic business.
- Fast growth of endovascular and electrophysiological segments.
- New Product Launch:
- VitaFlow™ (Transcatheter Aortic Valve and Delivery System) expected to be launched in 2018.
- Clinical fast track granted by CFDA in Aug 16.
- EU Market Expansion:
- Firehawk likely to be covered by medical insurance in Europe by end-2017.
- EU sales expected to surge from ~US$1m to over US$10m in the next few years.
- Acquisition:
- Acquired 17.4% stake in Lombard Medical, Inc. (NASDAQ: EVAR) for US$25.3m.
- Valuation:
- Current EV/EBITDA: 9.6x.
- Target price: HK$7.02, based on 12.0x 2017F EV/EBITDA.
Analysts' Top Alpha Picks
| Company | Ticker | Recommendation | Price 27 Jan 17 (HK$) | Target Price (HK$) | Upside/Downside (%) |
|---|---|---|---|---|---|
| Alibaba Group | BABA US | BUY | 100.84 | 130.00 | +29% |
| BEWG | 371 HK | BUY | 5.41 | 7.60 | +40.5% |
| CITICS | 6030 HK | BUY | 15.90 | 19.90 | +25.16% |
| CRCC | 1186 HK | BUY | 10.82 | 12.80 | +18.3% |
| CSPC | 1093 HK | BUY | 8.76 | 10.00 | +14.2% |
| China Southern Airlines | 1055 HK | BUY | 4.41 | 5.90 | +33.8% |
| Lee & Man Paper | 2314 HK | BUY | 7.01 | 8.00 | +14.1% |
| UMF | 2666 HK | BUY | 6.50 | 10.26 | +57.8% |
| Sunac China | 1918 HK | SELL | 6.92 | 4.34 | -37.3% |
| MGM China | 2282 HK | SELL | 14.80 | 12.50 | -15.5% |
Valuation Highlights
-
Alibaba Group:
- Trading at 21.8x FY17F PE.
- Valuation is considered attractive due to better profitability and strong earnings growth.
-
Microport:
- Target price: HK$7.02.
- Valuation based on 12.0x 2017F EV/EBITDA.
- Trading at 9.6x 2017F EV/EBITDA, which is a 15% premium over Shandong Weigao.
Summary of Key Insights
- Positive Trends: Strong growth in key sectors, including online marketing, cloud business, and containerboard prices.
- Market Catalysts: Upcoming results announcements, new PPP projects, and product launches are expected to drive performance.
- Valuation Adjustments: Some companies are trading at premium valuations, while others are undervalued with potential for growth.
- Risks: Overly aggressive landbanking, weak fundamentals, and potential price cuts can negatively impact certain stocks.
- Strategic Moves: Analysts are adjusting their investment positions based on performance and market conditions.
展开完整摘要
试读结束,高清完整版pdf/doc/ppt,请点下载